Inavir cleared for flu prevention in Japan
This article was originally published in Scrip
Executive Summary
Daiichi Sankyo's long-acting neuraminidase inhibitor Inavir (laninamivir octanoate) has been approved in Japan for the additional indication of prophylaxis of influenza types A and B.